Experimental drug AZD4144 put through drug interaction test
NCT ID NCT07685600
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This study investigates how the experimental drug AZD4144 behaves in the body when taken alone and with itraconazole, a common antifungal. Healthy adults aged 18-55 with a BMI between 18 and 30 are eligible. The goal is to measure drug levels and clearance, helping to guide future dosing.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AZD4144
- What this could lead to
- If successful, this study may help determine safe dosing for future trials of AZD4144.
- What could go wrong
- This is an early-phase study in healthy volunteers, so results may not predict effects in patients. The drug may not work as expected in later trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Which medical adhesive stays put longest without itching? a head-to-head test in healthy women.
- Avocado at breakfast: a secret weapon for blood sugar and fullness?
- New eye drop aims to tame ocular pain in early trial
- Could a formula closer to breast milk boost baby development?
- Could a daily probiotic help you feel fuller and eat less?